DGKB
Diacylglycerol kinase beta
Also known as: DAGK2, DGK, DGK-BETA, DGKB_HUMAN, KIAA0718
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6T7
- Gene
- DGKB
- Ensembl
- ENSG00000136267
- Chromosome
- 7
- Canonical length
- 804 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles,Plasma membrane
OverviewNCBI Gene
Diacylglycerol kinases (DGKs) are regulators of the intracellular concentration of the second messenger diacylglycerol (DAG) and thus play a key role in cellular processes. Nine mammalian isotypes have been identified, which are encoded by separate genes. Mammalian DGK isozymes contain a conserved catalytic (kinase) domain and a cysteine-rich domain (CRD). The protein encoded by this gene is a diacylglycerol kinase, beta isotype. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017]
Canonical amino-acid sequenceUniProt
804 residues, UniProt reviewed canonical sequence.
>Q9Y6T7|DGKB
1 MTNQEKWAHL SPSEFSQLQK YAEYSTKKLK DVLEEFHGNG VLAKYNPEGK QDILNQTIDF
61 EGFKLFMKTF LEAELPDDFT AHLFMSFSNK FPHSSPMVKS KPALLSGGLR MNKGAITPPR
121 TTSPANTCSP EVIHLKDIVC YLSLLERGRP EDKLEFMFRL YDTDGNGFLD SSELENIISQ
181 MMHVAEYLEW DVTELNPILH EMMEEIDYDH DGTVSLEEWI QGGMTTIPLL VLLGLENNVK
241 DDGQHVWRLK HFNKPAYCNL CLNMLIGVGK QGLCCSFCKY TVHERCVARA PPSCIKTYVK
301 SKRNTDVMHH YWVEGNCPTK CDKCHKTVKC YQGLTGLHCV WCQITLHNKC ASHLKPECDC
361 GPLKDHILPP TTICPVVLQT LPTSGVSVPE ERQSTVKKEK SGSQQPNKVI DKNKMQRANS
421 VTVDGQGLQV TPVPGTHPLL VFVNPKSGGK QGERIYRKFQ YLLNPRQVYS LSGNGPMPGL
481 NFFRDVPDFR VLACGGDGTV GWVLDCIEKA NVGKHPPVAI LPLGTGNDLA RCLRWGGGYE
541 GENLMKILKD IENSTEIMLD RWKFEVIPND KDEKGDPVPY SIINNYFSIG VDASIAHRFH
601 IMREKHPEKF NSRMKNKFWY FEFGTSETFS ATCKKLHESV EIECDGVQID LINISLEGIA
661 ILNIPSMHGG SNLWGESKKR RSHRRIEKKG SDKRTTVTDA KELKFASQDL SDQLLEVVGL
721 EGAMEMGQIY TGLKSAGRRL AQCSCVVIRT SKSLPMQIDG EPWMQTPCTI KITHKNQAPM
781 LMGPPPKTGL FCSLVKRTRN RSKELocalizationUniProt · AlphaFold · HPA
Whether an antibody against DGKB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 19 nTPM
- basal ganglia: 18 nTPM
- hippocampal formation: 4.7 nTPM
- amygdala: 4.4 nTPM
- hypothalamus: 4.4 nTPM
- endometrium: 3 nTPM
Single-cell type
- brain inhibitory neurons: 1,602 nCPM
- corticotrophs: 1,419 nCPM
- brain excitatory neurons: 803 nCPM
- retinal bipolar cells: 778 nCPM
- adrenal medulla cells: 755 nCPM
- other brain neurons: 655 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 102 nTPM
- cerebral cortex: 68 nTPM
- hypothalamus: 63 nTPM
- hippocampal formation: 43 nTPM
- white matter: 32 nTPM
- amygdala: 31 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.53
- gnomAD missense Z
- 1.95
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- diacylglycerol metabolic process
- glycerolipid metabolic process
- intracellular signal transduction
- lipid phosphorylation
- phosphatidic acid biosynthetic process
- phospholipase C-activating G protein-coupled receptor signaling pathway
- platelet activation
Molecular functions
- ATP binding
- ATP-dependent diacylglycerol kinase activity
- calcium ion binding
- lipid binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Diacylglycerol kinase, accessory domain
- Diacylglycerol kinase, catalytic domain
- EF-hand domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- EF-hand domain pair
- NAD kinase/diacylglycerol kinase-like domain superfamily
- Inorganic polyphosphate/ATP-NAD kinase, N-terminal
- EF-Hand 1, calcium-binding site
- Diacylglycerol kinase type I, N-terminal
- Diacylglycerol kinase
- DGK type I, N-terminal domain superfamily
- C1-like domain superfamily
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- Diacylglycerol kinase accessory domain
- Diacylglycerol kinase catalytic domain
- EF-hand domain pair
- Diacylglycerol kinase N-terminus
- Diacylglycerol kinase beta, second protein kinase C conserved region 1
- Diacylglycerol kinase beta-like, first protein kinase C conserved region 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DGKB as an antibody target. Whether an autoantibody or antibody against DGKB could matter depends on whether native DGKB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DGKB is annotated at the cell surface, where native DGKB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label DGKB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...